HANNAH ALISON L. (CIK 1645600) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-10). Recent activity: Buy RIGL (24,400 shares), Buy RIGL (5,750 shares), Buy NEO (12,254 shares), Buy NEO (12,254 shares), Buy RIGL (2,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Medical Officer | Buy | 24,400 | $0 |
| 2026-05-19 | RIGEL PHARMACEUTICALS INC (RIGL) | Director | Buy | 5,750 | $0 |
| 2025-06-03 | NEOGENOMICS INC (NEO) | Director | Buy | 12,254 | $0 |
| 2025-06-03 | NEOGENOMICS INC (NEO) | Director | Buy | 12,254 | $0 |
| 2025-05-28 | RIGEL PHARMACEUTICALS INC (RIGL) | Director | Buy | 2,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-10